Generics Unleashed: Jardiance Patent Expiry Rocks India’s Pharma Scene
March 11th, 2025, marked a seismic shift in India’s pharmaceutical landscape. With the patent expiry of Jardiance (empagliflozin)—a blockbuster anti-diabetic drug originally develo…
Read more
